We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$22.7B
AUM Growth
-$33.5M
(-0.15%)
Cap. Flow
-$2B
Cap. Flow
% of AUM
-8.79%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
2,101
New
297
Increased
583
Reduced
883
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$163M |
| 2 |
Merck
MRK
|
+$125M |
| 3 |
Royal Bank of Canada
RY
|
+$91.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$89.1M |
| 5 |
Bank of Montreal
BMO
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$126M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$104M |
| 3 |
Johnson Controls International
JCI
|
+$91.5M |
| 4 |
Oracle
ORCL
|
+$90M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.94% |
| 2 | Consumer Discretionary | 13.96% |
| 3 | Healthcare | 13.37% |
| 4 | Financials | 11.87% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Purple Innovation
PRPL
$33.2M
| $232K | ﹤0.01% |
294
-226
| -43% | -$196K |
|
1652
Franklin Covey
FC
$233M
| $231K | ﹤0.01% |
+8,182
| New | +$214K |
|
1653
Alexandria Real Estate Equities
ARE
$8.88B
| $230K | ﹤0.01% |
+1,400
| New | +$233K |
|
1654
Lakeland Financial Corp
LKFN
$1.52B
| $230K | ﹤0.01% |
+3,317
| New | +$218K |
|
1655
Acacia Research
ACTG
$450M
| $229K | ﹤0.01% |
34,500
+9,100
| +36% | +$57.3K |
|
1656
Assembly Biosciences
ASMB
$506M
| $229K | ﹤0.01% |
4,150
-9,761
| -70% | -$647K |
|
|
ZGNX
1657
DELISTED
Zogenix, Inc.
ZGNX
| $229K | ﹤0.01% |
11,720
-63,403
| -84% | -$1.3M |
|
1658
HF Sinclair
DINO
$15.9B
| $228K | ﹤0.01% |
6,382
-47,804
| -88% | -$1.6M |
|
1659
Qiagen
QGEN
$8.53B
| $227K | ﹤0.01% |
4,384
-157,129
| -97% | -$8.63M |
|
|
ECHO
1660
DELISTED
Echo Global Logistics, Inc.
ECHO
| $227K | ﹤0.01% |
+7,228
| New | +$210K |
|
1661
Eversource Energy
ES
$28.2B
| $226K | ﹤0.01% |
2,608
-53,606
| -95% | -$4.55M |
|
1662
The Joint Corp
JYNT
$119M
| $226K | ﹤0.01% |
+4,671
| New | +$175K |
|
|
BFX
1663
DELISTED
BowFlex Inc.
BFX
| $226K | ﹤0.01% |
14,420
+666
| +5% | +$14.3K |
|
1664
Winmark
WINA
$1.19B
| $225K | ﹤0.01% |
1,209
-5,503
| -82% | -$1M |
|
1665
FirstService
FSV
$6.32B
| $223K | ﹤0.01% |
+1,500
| New | +$218K |
|
1666
Mustang Bio
MBIO
$4.26M
| $223K | ﹤0.01% |
+90
| New | +$268K |
|
|
EVRI
1667
DELISTED
Everi Holdings
EVRI
| $222K | ﹤0.01% |
+15,703
| New | +$223K |
|
1668
Zumiez
ZUMZ
$320M
| $222K | ﹤0.01% |
5,187
-1,371
| -21% | -$61.1K |
|
1669
CRISPR Therapeutics
CRSP
$4.58B
| $221K | ﹤0.01% |
1,814
-23,012
| -93% | -$3.47M |
|
|
EXE
1670
Expand Energy Corp
EXE
$21.9B
| $221K | ﹤0.01% |
+5,100
| New | +$225K |
|
1671
Matsons
MATX
$6.37B
| $220K | ﹤0.01% |
+3,300
| New | +$226K |
|
1672
SPX Corp
SPXC
$11B
| $220K | ﹤0.01% |
+3,778
| New | +$215K |
|
1673
Hackett Group
HCKT
$245M
| $219K | ﹤0.01% |
13,359
-181,414
| -93% | -$2.81M |
|
1674
General Dynamics
GD
$105B
| $218K | ﹤0.01% |
1,201
-445
| -27% | -$72.7K |
|
1675
Ferrari
RACE
$63.3B
| $218K | ﹤0.01% |
+1,040
| New | +$213K |
|
Similar funds
Man Group's Q1 2021 Portfolio in Review
As of Q1 2021, Man Group held 2,101 positions worth $22.7B, down 0.15% from $22.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group withdrew a net $2B in Q1 2021, closing 273 positions and reducing 883 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $49.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Man Group opened a new position in iShares Russell 2000 Value ETF worth $45.3M.
- Man Group's largest Q1 2021 buy was iShares Russell 2000 Value ETF: 283,817 shares worth $45.3M.
- Man Group added most to Intel in Q1 2021, an estimated $163M increase.
- Man Group's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $126M.
- Man Group fully exited IHS Markit Ltd. Common Shares in Q1 2021, selling an estimated $49.1M.
- Man Group's ten largest holdings make up 17% of its $22.7B portfolio in Q1 2021.
- Man Group opened 297 new positions and closed 273 in Q1 2021.
- Man Group's portfolio value fell 0.15% quarter-over-quarter to $22.7B.
Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.